Historical record - last NADAC effective date: 4/17/2024

Product Information

LEVETIRACETAM 250 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.0548 per EA under NDC 13668001425. Its NADAC has been published 547 times since Nov 28, 2013.

FDA first approved this application on Jan 15, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVETIRACETAM 250 MG TABLET

Levetiracetam
$0.0548per EA

Strength

250 mg/1

NDC

13668001425

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

4/17/2024

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA078858

FDA Approved

1/15/2009

TE Code

AB

On Market Since

1/15/2009

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LEVETIRACETAM 250 MG TABLET has been published 547 times since Nov 28, 2013, and over the history we have for it it has declined 55.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0548 per EA
All-time high$0.1732 (Feb 12, 2014)
All-time low$0.0548 (Apr 17, 2024)
Median price$0.0858
Average price$0.0867
Largest weekly change+35.2% (Jan 22, 2014)
Weeks tracked547
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-18.5%

5Y

-38.4%

All

-55.5%

Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LEVETIRACETAM 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $0.0548 per EA (NDC 13668001425), effective May 15, 2024.

How has the price of LEVETIRACETAM 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has declined 55.5%. It has been tracked across 547 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?

Since Nov 28, 2013, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0548 (Apr 17, 2024) to a high of $0.1732 (Feb 12, 2014), with a median of $0.0858 per EA.

Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?

Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 10% below LEVETIRACETAM 250 MG TABLET.

Who manufactures LEVETIRACETAM 250 MG TABLET?

LEVETIRACETAM 250 MG TABLET (NDC 13668001425) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.